InvestorsHub Logo
Followers 47
Posts 5348
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Thursday, 12/15/2022 6:41:41 PM

Thursday, December 15, 2022 6:41:41 PM

Post# of 471379
As I watch the story unfold after being here for 6-7 years I see two patterns that are running parallel to each other almost to a “T” which is as clear as day.

One pattern or narrative being that the press/pharma world/AF henchmen have all either ignored Anavex or continued to claim that “Dr. Missling hasnt released all the data for x, y, and z trials therefore he must be hiding something or cherry picking etc all the while the MC gets drug through the streets. Maybe they are right about the hiding something in some aspects but that is not the whole story.

The other narrative is that each time Dr. Missling presents the data from each trial or milestone completed at conferences there is crickets and MC body slams. Therefore why would the leader of a small biotech open all of his hand up until he was able to completely and thoroughly accomplish his goal of gaining approval through submission on the data to the all important FDA, EMA, AU etc. This narrative is further supported with the partnering aspect as well. While frustrating on both accounts this latter narrative, which I and others lean towards, is needed in order for our drug to move independently past the approval milestone in order to assure that this drug does not get derailed in any way shape or form. It also allows Dr. Missling, who is well qualified, to make small alterations along the way.

So in closing the fact that not one trial ran has ever produced unsafe results or ineffective efficacy but rather all positive to date, quite positive in some cases! I think there are many that can more eloquently state my point so I apologize for the disjointed points but in the end I am led to believe…..WGT and big pharma knows it!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News